Search results
Decoding AbbVie Inc (ABBV): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 1 day agoAdditionally, AbbVie faces external threats from regulatory challenges and intellectual property disputes. By leveraging its strengths and addressing its...
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
CNBC· 4 days agoSales of AbbVie's Humira are plummeting as the once-top-selling drug fights competition from cheaper...
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
Zacks via Yahoo Finance· 4 days agoShares of this drugmaker have returned -10% over the past month versus the Zacks S&P 500 composite's...
Earnings call: AbbVie surpasses Q1 expectations, announces CEO transition By Investing.com
Investing.com· 6 days agoThe earnings call also marked a significant leadership transition, with CEO Rick Gonzalez announcing...
Investors Take AbbVie To The Woodshed. But Its Woes Are 'Unfounded.'Investors Take AbbVie To The...
Investor's Business Daily· 6 days agoOn Friday, AbbVie beat first-quarter expectations, largely on the back of its immunology franchise....
Barclays lowers AbbVie shares target on Humira sales erosion concerns By Investing.com
Investing.com· 6 days ago:ABBV) shares, reducing the price target to $187 from the previous $195. The revision was attributed...
AbbVie (ABBV) Could Be a Great Choice
Zacks via Yahoo Finance· 5 days agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
AbbVie (NYSE:ABBV) Price Target Cut to $180.00 by Analysts at BMO Capital Markets
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Free Report) had its price objective cut by BMO Capital Markets from $195.00 to $180.00 in a report published on Monday morning, Benzinga reports. A number ...
AbbVie (NYSE:ABBV) Price Target Cut to $187.00
ETF DAILY NEWS· 4 days agoAbbVie (NYSE:ABBV – Get Free Report) had its target price cut by equities researchers at Barclays from $195.00 to $187.00 in a research report issued on Monday, Benzinga reports ...
The top pharmaceutical companies by R&D expenditure
Pharmaceutical Technology via Yahoo Finance· 3 days agoLast year, major pharmaceutical companies heavily invested in R&D, with expenditure ranging from around 14% to 50% of their revenues. Some of the...
